MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $31,000 | -59.7% | 25,000 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $77,000 | -24.5% | 25,000 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $102,000 | -35.8% | 25,000 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $159,000 | +17.8% | 25,000 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $135,000 | -35.4% | 25,000 | 0.0% | 0.00% | -40.0% |
| Q1 2016 | $209,000 | +5.6% | 25,000 | 0.0% | 0.01% | +25.0% |
| Q4 2015 | $198,000 | -7.0% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $213,000 | -9.4% | 25,000 | +31.6% | 0.00% | +33.3% |
| Q2 2015 | $235,000 | +4.0% | 19,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $226,000 | +66.2% | 19,000 | +58.3% | 0.00% | +50.0% |
| Q4 2014 | $136,000 | +29.5% | 12,000 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $105,000 | +20.7% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $87,000 | +45.0% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $60,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GARRISON BRADFORD & ASSOCIATES INC | 98,001 | $661,000 | 0.71% |
| Tekla Capital Management LLC | 537,600 | $3,618,000 | 0.49% |
| CAMBRIDGE TRUST CO | 239,003 | $1,611,000 | 0.17% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,067,538 | $7,185,000 | 0.14% |
| Asset Management Group, Inc. | 29,453 | $199,000 | 0.14% |
| Magnetar Financial LLC | 754,837 | $5,080,000 | 0.11% |
| Trellus Management Company, LLC | 11,000 | $74,000 | 0.09% |
| JAMISON EATON & WOOD INC /NJ | 42,042 | $283,000 | 0.08% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1,491,850 | $10,055,000 | 0.07% |
| NORTH AMERICAN MANAGEMENT CORP | 45,000 | $303,000 | 0.06% |